Regeneron Pharmaceuticals shares owned by Natixis
Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Natixis
from 13F filings
Historical chart of Natixis investment in Regeneron Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Regeneron Pharmaceuticals held by Natixis consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Regeneron Pharmaceuticals by Natixis
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $36M | 64k | 562.27 |
| 2025-06-30 | $38M | 72k | 525.00 |
| 2025-03-31 | $44M | 69k | 635.50 |
| 2024-12-31 | $65M | 91k | 712.33 |
| 2024-09-30 | $57M | 55k | 1051.24 |
| 2024-06-30 | $26M | 24k | 1051.03 |
| 2024-03-31 | $5.3M | 5.5k | 962.49 |
| 2023-09-30 | $11M | 13k | 822.96 |
| 2023-06-30 | $9.1M | 13k | 718.54 |
| 2023-03-31 | $4.7M | 5.7k | 821.67 |
| 2022-12-31 | $21M | 28k | 721.49 |
| 2022-09-30 | $20M | 28k | 693.57 |
| 2022-06-30 | $30M | 50k | 591.97 |
| 2022-03-31 | $92M | 132k | 698.42 |
| 2021-12-31 | $11M | 18k | 631.52 |
| 2021-09-30 | $7.9M | 13k | 605.15 |
| 2021-03-31 | $13M | 27k | 473.15 |
| 2020-12-31 | $12M | 25k | 483.10 |
| 2020-09-30 | $5.7M | 10k | 559.79 |
| 2020-06-30 | $80M | 128k | 623.65 |
| 2020-03-31 | $4.4M | 9.0k | 488.29 |
| 2019-12-31 | $2.1M | 5.7k | 373.73 |
| 2019-06-30 | $18M | 58k | 313.00 |
| 2019-03-31 | $24M | 58k | 404.83 |
| 2018-09-30 | $611k | 1.5k | 404.10 |
| 2017-12-31 | $1.8M | 4.9k | 376.05 |
| 2017-09-30 | $9.1M | 20k | 447.13 |
| 2017-03-31 | $1.3M | 3.3k | 387.42 |
| 2016-12-31 | $3.3M | 9.0k | 367.13 |
| 2014-06-30 | $2.0M | 7.0k | 282.44 |